NEWS
You can follow the latest news of MicroViable in this section
Microviable attends the most important international congresses
During 2023 Microviable Therapeutics has attended several leading events in the fields of microbiota, pharma and investment. In some cases we have participated as speakers with presentations and posters. This is the case of Microbiome [...]
Microbiome in the spotlight during the 2023 Princess of Asturias awards
The experts’ committee of the Princess of Asturias awards has decided to grant this year´s award for technical and scientific research to Jeffrey Gordon, Bonnie L. Bassler and E. Peter Greenberg, experts and pioneers in [...]
Microviable Therapeutics attended the talks of Bonnie L. Bassler and Peter Greenberg
Last Tuesday, Microviable Therapeutics attended the talks of Bonnie L. Bassler and Peter Greenberg, 2023 Princess of Asturias of Scientific and Technical research awards. Both explained their work on the phenomenon of quorum sensing, the [...]
Microviable will be attending HLTH 2023. Las Vegas, October 8-11
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending HLTH 2023 event in Las Vegas (USA) from October 8th to 11th. HLTH 2023 is the preeminent event [...]
Microbiota and Infectious Disease Treatments: A Solution to Antibiotic Resistance
In today's world, antibiotic resistance and multi-resistant bacteria pose a challenge to modern medicine. Innovative therapies involving microbiota and treatments for infectious diseases offer a promising solution to address this issue. The diverse community of [...]
Microviable Therapeutics will be attending BioSpain 2023
Claudio Hidalgo, CEO at Microviable, will be attending BioSpain 2023, one of the largest international biotechnology events in southern Europe, will take place from 26-28 September 2023 in Barcelona thanks to a coordinated collaboration of [...]